Source:http://linkedlifedata.com/resource/pubmed/id/18255189
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2008-3-11
|
pubmed:abstractText |
We investigated the effect of topical temporin A in the management of methicillin-resistant strain of Staphylococcus aureus (MRSA)-infected experimental surgical wounds in mice. The wound, cut through the panniculus carnosus of BALB/c mice, was inoculated with 5x10(7) colony-forming units of MRSA. Mice were treated with Allevyn, temporin A-soaked Allevyn, Allevyn and daily intraperitoneal teicoplanin (7mg/kg), temporin A-soaked Allevyn and daily intraperitoneal teicoplanin. Main outcome measurements were: quantitative bacterial culture, histological examination with assessment of micro-vessel density and of vascular endothelial growth factor (VEGF) expression in tissue sections, and VEGF plasma levels alike. Treatment with temporin-A associated with teicoplanin injection significantly reduced bacterial load to 0.85 x 10(1)+/-0.1 x 10(1)CFU/ml. Histological examination showed that infected mice receiving temporin A-soaked Allevyn (with or without teicoplanin) had a higher degree of granulation tissue formation and collagen deposition compared to the other treated groups. A significant increase in serum VEGF expression was observed in mice receiving temporin A topically and temporin A topically associated with intraperitoneal teicoplanin. In conclusion our results demonstrated that temporin A is effective in the management of infected wounds, by a significant bacterial growth inhibition and acceleration of wound repair process.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0196-9781
|
pubmed:author |
pubmed-author:BaruccaClaudiaC,
pubmed-author:CirioniOscarO,
pubmed-author:GhiselliRobertoR,
pubmed-author:GiacomettiAndreaA,
pubmed-author:GoteriGaiaG,
pubmed-author:KamyszElzbietaE,
pubmed-author:KamyszWojciechW,
pubmed-author:OffidaniAnnamariaA,
pubmed-author:OrlandoFiorenzaF,
pubmed-author:SabaVittorioV,
pubmed-author:ScaliseAlessandroA,
pubmed-author:ScaliseGiorgioG,
pubmed-author:SilvestriCarmelaC,
pubmed-author:SimonettiOrianaO
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
520-8
|
pubmed:meshHeading |
pubmed-meshheading:18255189-Animals,
pubmed-meshheading:18255189-Anti-Bacterial Agents,
pubmed-meshheading:18255189-Male,
pubmed-meshheading:18255189-Methicillin Resistance,
pubmed-meshheading:18255189-Mice,
pubmed-meshheading:18255189-Mice, Inbred BALB C,
pubmed-meshheading:18255189-Models, Animal,
pubmed-meshheading:18255189-Neovascularization, Pathologic,
pubmed-meshheading:18255189-Proteins,
pubmed-meshheading:18255189-Staphylococcal Infections,
pubmed-meshheading:18255189-Staphylococcus aureus,
pubmed-meshheading:18255189-Vascular Endothelial Growth Factor A,
pubmed-meshheading:18255189-Wound Healing,
pubmed-meshheading:18255189-Wound Infection
|
pubmed:year |
2008
|
pubmed:articleTitle |
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model.
|
pubmed:affiliation |
Dermatological Clinic, Università Politecnica delle Marche, Ancona, Italy. o.simonetti@univpm.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|